Please wait
0001420565EX-FILING FEESCommon stock0.0001531N/AN/A 0001420565 2025-09-03 2025-09-03 0001420565 1 2025-09-03 2025-09-03 iso4217:USD xbrli:pure xbrli:shares
Exhibit 107
Calculation of Filing Fee Tables
Form
S-1
(Form Type)
Rein Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
 
     
Security 
Type 
     
Security 
Class 
Title 
   
Fee 
Calculation 
Rule 
  
Amount 
Registered 
(a) 
     
Proposed 
Maximum 
Offering 
Price Per 
Unit (b) 
     
Maximum 
Aggregate 
Offering 
Price (b) 
     
Fee Rate 
     
Amount of 
Registration 
Fee 
  
Fees to Be
Paid
      Equity      
Common
 
stock 
    457(c)     10,000,000         $1.35        $13,500,000        
 $
153.10
 per 
$1,000,000 
  
 
      $2,066.85   
    
 
Total Offering Amounts
 
               $13,500,000                  $2,066.85   
    
 
Total Fee Offsets
 
                                 —  
    
 
Net Fee Due
 
                                 $2,066.85   
 
(a)
In accordance with Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall be deemed to cover an indeterminate number of additional shares of Common Stock to be offered or issued from stock splits, stock dividends or similar transactions.
(b)
Estimated solely for purposes of calculating the registration fee in accordance with Rule 457(c) under the Securities Act and based upon the average of the high and low sales prices of a share of common stock as reported on the Nasdaq Capital Market on September 2, 2025.